Merck, which is evaluating the safety and efficacy of enlicitide for the treatment of adults with hyperlipidemia on lipid-lowering therapies, including at least a statin, said the Phase 3 studies ...

Quad has officially pulled the curtain back on the new Quad 3 integrated amplifier—a slickly retro-styled unit that looks straight out of a 1960s bachelor pad, but under the hood, it’s packing ...

Merck & Co. said its oral PCSK9 inhibitor candidate enlicitide hit its key goals in a pair of late-stage studies in adults with high cholesterol. Merck, which is evaluating the safety and efficacy ...

ENLIGHTEN 2 trial met primary endpoint with LYR-210 demonstrating statistically significant improvement in the composite of the three cardinal symptoms (3CS) of CRS at 24 weeks (p=0.0078)ENLIGHTEN ...

UPDATE: Apr. 24, 2025, 3:29 p.m. EDT This story has been updated with additional photos of the Switch 2 and its accessories, as well as new details about the console's social features and preorder ...

Regeneron Pharmaceuticals and Sanofi announced that their Phase 3 clinical trial, AERIFY-1, showed a significant 27% reduction in moderate to severe exacerbations of COPD in former smokers treated ...

Patients were stratified by nodal and hormone receptor status and randomized (1:1) to receive six 3-week cycles of an investigator-selected taxane (docetaxel, paclitaxel or nab-paclitaxel) plus ...

Elden Ring Nightreign will soon let players drop into the shifting lands of Limveld, exploring and fighting for survival either solo or in groups of three. For the duos out there though, it sounds ...

Background: The addition of immune checkpoint inhibitors to neoadjuvant/adjuvant SOC has led to efficacy benefits across multiple tumor types. The randomized phase 3 KEYNOTE-689 study (NCT03765918) ...

With Phase 2 operational, Metro services will cover 20 km of the total 33.35 km corridor, allowing passengers to travel between Aarey and Worli (Acharya Atre Chowk). Inspections of six stations ...

Following the news of two lecanemab-related deaths reported on the eve of the Clinical Trials on Alzheimer’s Disease (CTAD) 2022 conference, Eisai has now presented the full results from its ...